IGC Pharma, Inc. (IGC) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering IGC Pharma, Inc. (IGC), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For IGC Pharma, Inc., analysts forecast revenue falling from $22.20M in 2023 to $857,000 in 2028; the average estimate for 2028 earnings per share is −$0.08; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
IGC Pharma, Inc. (IGC) forecast — frequently asked questions
What are analysts forecasting for IGC Pharma, Inc.'s earnings?
The average analyst estimate for IGC Pharma, Inc. (IGC) earnings per share in 2028 is -0.08, with individual estimates between -0.08 and -0.08.
How much revenue is IGC Pharma, Inc. expected to make?
Analysts forecast IGC Pharma, Inc. (IGC) revenue of $857,000 in 2028, based on 1 published estimates.
How many analysts cover IGC?
1 analyst contribute estimates for IGC Pharma, Inc. (IGC). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.